Rick Scalzo
Director Financiero/CFO en DYNE THERAPEUTICS, INC. .
Fortuna: 4 M $ al 31/05/2024
Cargos activos de Rick Scalzo
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DYNE THERAPEUTICS, INC. | Director Administrativo | 01/07/2020 | - |
| Director Financiero/CFO | 01/07/2020 | - | |
| Treasurer | 01/07/2020 | 02/07/2020 |
Historial de carrera de Rick Scalzo
Antiguos cargos conocidos de Rick Scalzo.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/08/2018 | 29/11/2019 |
| X4 PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/09/2016 | 01/08/2018 |
| OCATA THERAPEUTICS INC | Comptroller/Controller/Auditor | 01/08/2014 | 01/09/2014 |
Formación de Rick Scalzo.
| University of Massachusetts | Masters Business Admin |
| Boston College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Rick Scalzo
- Experiencia
